Enhanced prediction of beta-secretase inhibitory compounds with mol2vec technique and machine learning algorithms

A comprehensive computational strategy that combined QSAR modelling, molecular docking, and ADMET analysis was used to discover potential inhibitors for β-secretase 1 (BACE-1). A dataset of 1,138 compounds with established BACE-1 inhibitory activities was used to build a QSAR model using mol2vec descriptors and support vector regression. The obtained model demonstrated strong predictive performance (training set: <i>r</i>² = 0.790, RMSE = 0.540, MAE = 0.362; test set: <i>r</i>² = 0.705, RMSE = 0.641, MAE = 0.495), indicating its reliability in identifying potent BACE-1 inhibitors. By applying this QSAR model together with molecular docking, seven compounds (ZINC8790287, ZINC20464117, ZINC8878274, ZINC96116481, ZINC217682404, ZINC217786309 and ZINC96113994) were identified as promising candidates, exhibiting predicted log IC₅₀ values ranging from 0.361 to 1.993 and binding energies ranging from −10.8 to −10.7 kcal/mol. Further analysis using ADMET studies and molecular dynamics simulations provided further support for the potential of compound 279 (ZINC96116481) and compound 945 (ZINC96113994) as drug candidates. However, since our study is purely theoretical, further experimental validation through in vitro and in vivo studies is essential to confirm these promising findings.